Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D)

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/f4/26/b1/f426b171-37ac-38d3-a527-9da986f93a60/mza_14775525009803100300.jpeg/600x600bb.jpg

eDiabetes Review

24 episodes

2 months ago

eDiabetes Review podcast brings the journal club to you. Our moderator and expert faculty members analyze recently published and clinically relevant literature and then explain, with real-world case presentations, how you can apply the new data to your practice. Stay up to date on the rapidly changing world of diabetes while earning CME credits. All available at no cost or prerequisite and on your schedule.

Hosted on Acast. See acast.com/privacy for more information.

Medicine

Health & Fitness

RSS

All content for eDiabetes Review is the property of eDiabetes Review and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Hosted on Acast. See acast.com/privacy for more information.

Medicine

Health & Fitness

https://assets.pippa.io/shows/5fa6e50e5686194f10370b5d/1606931163889-9d9baff701986ce1c4fc747564c1da5d.jpeg

Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D)

eDiabetes Review

9 minutes 31 seconds

9 years ago

Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D)

Volume 2, Issue 13, Part 3.

Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Marc Rendell from Creighton University School of Medicine about the study: Efficacy and Safety of MK-1293 Insulin Glargine Compared Along with Originator Insulin Glargine (Lantus) in Type 2 Diabetes, presented at the June 2016 American Diabetes Association Scientific Session.

The post Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D) appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.